Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications:: should we CARE-2 avoid them?

被引：25
|
作者：
Floege, Juergen [1 ]
机构：
[1] Rhein Westfal TH Aachen, Div Nephrol & Immunol, D-52074 Aachen, Germany
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2008年 / 23卷 / 10期
关键词：
calcification; calcium acetate; dialysis; phosphate binder; sevelamer;
D O I：
10.1093/ndt/gfn393
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：3050 / 3052
页数：3
相关论文
共 8 条
  • [1] Comparative Effectiveness of Calcium-Containing Phosphate Binders in Incident US Dialysis Patients
    Winkelmayer, Wolfgang C.
    Liu, Jun
    Kestenbaum, Bryan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (01): : 175 - 183
  • [2] Effects of calcium-containing phosphate binders on cardiovascular events and mortality in predialysis CKD stage 5 patients
    Tsai, Ping-Huang
    Chung, Chi-Hsiang
    Chien, Wu-Chien
    Chu, Pauling
    PLOS ONE, 2020, 15 (10):
  • [3] A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients
    McIntyre, CW
    Patel, V
    Taylor, GS
    Fluck, RJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (09) : 1643 - 1648
  • [4] Real-world prescribing and switching patterns of non-calcium containing phosphate binders in dialysis patients in South Korea
    Kim, Jong Joo
    Kim, Myeong Gyu
    Park, Sung Cheol
    Hwang, Jinseub
    Sohn, Hyun Soon
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (03) : 166 - 173
  • [5] K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?
    Wei, Mingxin
    Taskapan, Hulya
    Esbaei, Khaled
    Jassal, Sarbjit Vanita
    Bargman, Joanne M.
    Oreopoulos, Dirnitrios G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (3-4) : 739 - 743
  • [6] K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?
    Mingxin Wei
    Hulya Taskapan
    Khaled Esbaei
    Sarbjit Vanita Jassal
    Joanne M. Bargman
    Dimitrios G. Oreopoulos
    International Urology and Nephrology, 2006, 38 : 739 - 743
  • [7] The effects of non-calcium-based phosphate binders versus calcium-based phosphate binders on cardiovascular calcification and bone remodeling among dialysis patients: a meta-analysis of randomized trials
    Liu, Ling
    Wang, Yongjun
    Chen, Hongyu
    Zhu, Xiaoling
    Zhou, Liusha
    Yang, Yazhen
    RENAL FAILURE, 2014, 36 (08) : 1244 - 1252
  • [8] Evaluation of Morbidity and Mortality Data Related to Cardiovascular Calcification from Calcium-Containing Phosphate Binder Use in Patients Undergoing Hemodialysis
    Mason, Molly A.
    Shepler, Brian M.
    PHARMACOTHERAPY, 2010, 30 (07): : 741 - 748
1